Indian Covaxin to be permitted for trial in Bangladesh
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
  • Epaper
  • More
    • Subscribe
    • COVID-19
    • Bangladesh
    • Splash
    • Videos
    • Games
    • Long Read
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard

Friday
August 12, 2022

Sign In
Subscribe
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
  • Epaper
  • More
    • Subscribe
    • COVID-19
    • Bangladesh
    • Splash
    • Videos
    • Games
    • Long Read
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
FRIDAY, AUGUST 12, 2022
Indian Covaxin to be permitted for trial in Bangladesh

Covid-19 in Bangladesh

TBS Report
03 August, 2021, 08:35 pm
Last modified: 03 August, 2021, 08:39 pm

Related News

  • Jagdeep Dhankhar takes oath as 14th Vice President of India
  • Google opposes Facebook-backed proposal for self-regulatory body in India
  • India begins trial run for trans-shipment of goods to NE via Bangladesh port
  • India could scrap wheat import duty to cool domestic prices, say sources
  • More Chinese women delay or give up on having babies after zero-Covid ordeal

Indian Covaxin to be permitted for trial in Bangladesh

TBS Report
03 August, 2021, 08:35 pm
Last modified: 03 August, 2021, 08:39 pm
Indian Covaxin to be permitted for trial in Bangladesh

Covid-19 vaccine Covaxin, by Indian company Bharat Biotech, is going to get approval for a clinical trial in Bangladesh. 

The Bangladesh Medical and Research Council has set some conditions in response to a request for the trial from the company. 

If the conditions are met, Bharat Biotech will soon get approval for a human trial in Bangladesh, Professor Dr Ruhul Amin, director, Bangladesh Medical Research Council (BMRC), told The Business Standard on Tuesday.

"The conditions are easy. There were a few mistakes in the application and we sent a letter to them in the third week of July saying that we will approve it if those are corrected. We have not received any reply yet," he said.

After the approval of BMRC, approval from the Department of Drug Administration is required to bring the vaccine sample to Bangladesh before the trial starts, he added.

Bharat Biotech and the Indian Council of Scientific Research have jointly developed Covaxin which was approved for emergency use in India last January. 

Subsequently, an application was made to the government of Bangladesh in mid-January to conduct a clinical trial of the vaccine in Bangladesh.
Bharat Biotech will implement this vaccine experimentally in Bangladesh through icddr,b.

Top News

India / COVAXIN / human trial

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Default loans jump Tk22,000cr in six months
    Default loans jump Tk22,000cr in six months
  • File Photo: Mohammad Minhaj Uddin/TBS
    ICDs hike imports handling charge by 35%
  • A shopping cart is seen in a supermarket as inflation affected consumer prices in Manhattan, New York City, US on 10 June 2022. REUTERS/Andrew Kelly
    Is global inflation nearing a peak?

MOST VIEWED

  • Photo: Courtesy
    US supports Bangladesh’s pediatric Covid-19 vaccination campaign
  • Photo: Collected
    Bangladesh logs 1 death, 214 Covid cases in 24 hours
  • Photo: Rajib Dhar/TBS
    Children 5-11 in age get first Covid vaccine shot
  • Representational image. Picture: Collected
    16 children to get trial Covid jabs on Thursday
  • Photo: Collected
    1 Covid death, 198 cases reported in a day
  • Illustration: Collected
    1 Covid death, 239 cases reported in 24hrs

Related News

  • Jagdeep Dhankhar takes oath as 14th Vice President of India
  • Google opposes Facebook-backed proposal for self-regulatory body in India
  • India begins trial run for trans-shipment of goods to NE via Bangladesh port
  • India could scrap wheat import duty to cool domestic prices, say sources
  • More Chinese women delay or give up on having babies after zero-Covid ordeal

Features

Bye bye! Photographer: Michael Zarrilli/Getty Images North America via Bloomberg

Three major takeaways from the FBI search on Trump’s home

18h | Panorama
Photo: Noor A Alam/TBS

Big dreams in small rooms: The aspiring nurses of Geneva Camp

21h | Panorama
Illustration: TBS

How to deal with toxic people at work

22h | Pursuit
Women were more likely to report leaving the workforce between March 2020 and September 2021 than their male counterparts. PHOTO: BLOOMBERG

Being single and smart is bad for your career if you are a woman

21h | Pursuit

More Videos from TBS

Control on liquor import boosts local Carew sales

Control on liquor import boosts local Carew sales

10h | Videos
Is Bangladesh losing opportunity to sent more expats to the Middle East?

Is Bangladesh losing opportunity to sent more expats to the Middle East?

11h | Videos
When hassles at airport will come to an end?

When hassles at airport will come to an end?

14h | Videos
How to spot a Pyramid Scheme?

How to spot a Pyramid Scheme?

14h | Videos

Most Read

1
Dollar crisis: BB orders removal of 6 banks’ treasury chiefs 
Banking

Dollar crisis: BB orders removal of 6 banks’ treasury chiefs 

2
Diesel price hiked by Tk34 per litre, Octane by Tk46
Energy

Diesel price hiked by Tk34 per litre, Octane by Tk46

3
Photo: Collected
Transport

Will Tokyo’s traffic model solve Dhaka’s gridlocks?

4
Arrest warrant against Habib Group chairman, 4 others 
Crime

Arrest warrant against Habib Group chairman, 4 others 

5
File Photo: State Minister for Power, Energy and Mineral Resources Nasrul Hamid
Energy

All factories to remain closed once a week under rationing system

6
Anwar Group looks beyond slowdown – invests Tk5,000cr
Economy

Anwar Group looks beyond slowdown – invests Tk5,000cr

EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2022
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net